The primary structures of three human neutrophil antimicrobial peptides (HNP) were determined. The peptides, HNP-1, HNP-2, and HNP-3, which we have termed defensins, were rich in cystine, arginine, and aromatic residues, but were devoid of free sulfhydryl groups and carbohydrate moieties. They were 29-30 residues in length and identical in sequence in all but their amino terminal residues. The defensins were homologous in sequence to peptides of similar size and biological activity previously purified from rabbit polymorphonuclear leukocytes, but unrelated to other neutrophil proteins of known sequence. 11 amino acid residues of the human defensins, including all six cysteinyl residues, were invariantly conserved in the six rabbit members of this multigene peptide family. That similarly structured antimicrobial peptides are present in both rabbit and human leukocytes supports their purported role as cidal agents in phagocyte-mediated host defense.
Introduction
Prominent among the "oxygen-independent" antimicrobial substances isolated from mammalian neutrophils, are a family of low molecular weight cationic peptides exemplified by those recently characterized in rabbit polymorphonuclear leukocytes (PMN) .' Six rabbit peptides have been purified to homogeneity and have been found to be active against gram-positive and gramnegative bacteria (1), fungi (2) , and herpes simplex virus (3) . The peptides were cysteine-rich and arginine-rich, 33-34 residues in length, and within their primary structures, each contained a conserved core of 11 residues (4). The unique structural and functional features of the rabbit peptide family led us to search for peptides ofsimilar size and biological activity in human PMN. Three human neutrophil peptides (HNP), individually named defensins exerted prominent antibacterial, antifungal, and antiviral effects in vitro, and were localized immunohistochemically to azurophil granules.
We now report the amino acid sequences of the three human neutrophil defensins. The structures ofthese peptides were highly conserved and were homologous in sequence to the rabbit neutrophil peptide family.
Methods
Purification ofhuman defensins. HNP-1, HNP-2, and HNP-3 were purified as recently described (5) . Briefly, human blood neutrophils were purified from leukopheresis packs to >90% PMN. A granule-rich subcellular fraction was obtained by homogenization and differential centrifugation steps. Granule protein, obtained by acetic acid extraction, was fractionated by gel filtration on a Bio-Gel P-10 column. Homogeneously pure HNP-1, HNP-2, and HNP-3 were obtained by subsequent ion-exchange, gel filtration, and reverse-phase high performance liquid chromatography (RP-HPLC) steps.
S-Alkylation ofHNP 1-3. Each peptide was reduced and alkylated with iodoacetic acid or iodoacetamide in 6.0 M guanidine hydrochloride, 0.5 M Tris-HCI, pH 8.5, 0.2 mM EDTA as previously described (6) . The carboxymethyl or carboxamidomethyl peptide derivatives were then desalted by RP-HPLC purification on a 10 X 250 mm C-18 column (Vydac; 18 h (S. aureus V protease) at 370C. Digestion products were purified by RP-HPLC on a 4.6 X 250 mm Vydac 300 A C-18 column as previously described (6) . Purified fiagments were hydrolyzed and subjected to amino acid analysis as described above. Sequence determination. 10-20 nmol of S-carboxamidomethylated HNP-1, HNP-2, and HNP-3 were subjected to gas-phase Edman degradation on an Applied Biosystems, Inc. (Foster City, CA) instrument, essentially as described in reference 12. Phenylthiohydantoin (PTH) amino acids were identified by RP-HPLC on a Zorbax cyanopropyl column (5 um, 4.5 X 250 mm) as previously described (6) .
The carboxyl terminal segment of each defensin was identified and characterized by the tritium-label method of Matsuo and Narita (13) . Briefly, each defensin was labeled with tritium at its carboxyl terminus and then digested with trypsin. The digestion fragments were purified by RP-HPLC, and the tritium-containing fragments were characterized by amino acid analysis (6) . Carboxypeptidase Y digestion of each peptide was performed as described in reference 14. Briefly, samples of each carboxymethylated HNP were digested with 1.0% (wt/wt) carboxypeptidase Y in 0.1 M pyridine-acetate, pH 6.35, for 1, 2, 4, 6, or 10 min at 370C. Samples were snap-frozen, lyophilized, and derivatized with PITC for amino acid analysis. Samples of the derivatized digest were injected onto the C-18 amino acid column without prior fractionation.
Results
The chemical compositions of the three defensins were nearly identical (Table I) . Each contained six half-cystine and four arginine residues, as well as an abundance of A280 absorbing aromatic residues. The single tryptophan and three tyrosine residues contained in each peptide were consonant with the high extinction coefficients of the defensins: in 0.1% acetic acid, the A2801% for HNP-1 and HNP-3 was 30.3, and for HNP-2 was 31.3. None of the peptides contained detectable carbohydrate. A, alanine; R, arginine; N, asparagine; D, aspartic acid; C, cysteine; Q, glutamine; E, glutamic acid; G, glycine; H, histidine; I, isoleucine; L, leucine; K, lysine; F, phenylalanine; P, proline; S, serine; T, threonine; W, tryptophan; Y. tyrosine; V, valine.
groups, suggesting that the six half-cystine residues of each peptide existed as three intramolecular disulfides.
The primary structures ofthe defensins were determined by automated Edman degradation and confirmed by characterization of purified proteolytic digestion fragments. As shown in Table II , phenylthiohydantoin (PTH)-amino acid residues from 29 (HNP-2) or 30 (HNP-1 and HNP-3) sequencing cycles were identified. The final residue obtained in each of the sequencing runs was determined to be the actual carboxyl terminal residue by (a) amino acid analysis of the tryptic fragments generated by digestion of carboxyl terminal tritium-labeled HNP, and (b) by the appearance of S-carboxymethylcysteine as the first residue released by carboxypeptidase Y degradation (data not shown). The sequences of the defensins, shown in Fig. 1 , contained four trypsin sites (four arginines), and one S. aureus V protease site (glutamic acid). The single tryptic fragment not containing arginine (T-5) was necessarily the carboxyl terminal fragment and this fragment contained the great majority of tritium counts. The sequences of the carboxyl terminal regions were further confirmed by characterizing the purified chymotryptic peptides (CT-1, CT-2, and CT-3) generated by digestion of tryptic peptide T-5. As demonstrated in Fig. 1 , the sequences of the three defensins were identical in all but their amino terminal residues.
The primary structures ofthe human defensins and the previously characterized rabbit PMN peptides were compared as shown in Fig. 2 When aligned as in Fig. 2 , the six rabbit and three human PMN peptides showed complete conservation of 11 residues, including all six cysteinyl residues. The absence of free-sulffiydryl 2. Since first our initial report of the rabbit peptide sequences, we have concluded that NP-5 contains 33 residues (compared with 32 originally reported). The carboxyl terminal arginine shown in Fig. 2 (15) , the existence oflow molecular weight human antibiotic peptides homologous to those previously shown in rabbit PMN has not previously been described. Perhaps one reason that the human homologs have gone undetected is that attention has been focused on the cationicity of some of these peptides, as evidenced by the designation of the rabbit PMN peptides as "lysosomal cationic proteins" (15) . While the defensins each possess a net positive charge at pH 7.0, their electrophoretic migration in low pH polyacrylamide gel electrophoresis is less cathodal than lysozyme (5), which possesses a computed net charge of +8 (16) .
Our sequence data suggests that although certain arginine residues may be of primary consequence, it is the cystine infrastructure, and by inference the molecular conformation, that appears essential for biological activity. The expression and perpetuation of homologous antibiotic peptides in granulocytes of two evolutionarily distinct species is consistent with the possibility that such antimicrobial peptides play a significant role in granulocyte function. 
